These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 30236844)
1. The biodegradation of cefuroxime, cefotaxime and cefpirome by the synthetic consortium with probiotic Bacillus clausii and investigation of their potential biodegradation pathways. Kong XX; Jiang JL; Qiao B; Liu H; Cheng JS; Yuan YJ Sci Total Environ; 2019 Feb; 651(Pt 1):271-280. PubMed ID: 30236844 [TBL] [Abstract][Full Text] [Related]
2. Bio-removal of tetracycline antibiotics under the consortium with probiotics Bacillus clausii T and Bacillus amyloliquefaciens producing biosurfactants. Liu CX; Xu QM; Yu SC; Cheng JS; Yuan YJ Sci Total Environ; 2020 Mar; 710():136329. PubMed ID: 31918182 [TBL] [Abstract][Full Text] [Related]
3. Secreted Compounds of the Probiotic Bacillus clausii Strain O/C Inhibit the Cytotoxic Effects Induced by Clostridium difficile and Bacillus cereus Toxins. Ripert G; Racedo SM; Elie AM; Jacquot C; Bressollier P; Urdaci MC Antimicrob Agents Chemother; 2016 Jun; 60(6):3445-54. PubMed ID: 27001810 [TBL] [Abstract][Full Text] [Related]
4. Quantitative and qualitative characterization of commercially available oral suspension of probiotic products containing Bacillus Clausii spores. Kharwar A; Bazaz MR; Dandekar MP BMC Microbiol; 2022 Sep; 22(1):217. PubMed ID: 36114449 [TBL] [Abstract][Full Text] [Related]
5. Immunological properties of beta-lactamases that hydrolyze cefuroxime and cefotaxime. Hirai K; Sato K; Matsubara N; Katsumata R; Inoue M; Mitsuhashi S Antimicrob Agents Chemother; 1981 Aug; 20(2):262-4. PubMed ID: 6269489 [TBL] [Abstract][Full Text] [Related]
6. Characterization and high-efficiency secreted expression in Bacillus subtilis of a thermo-alkaline β-mannanase from an alkaliphilic Bacillus clausii strain S10. Zhou C; Xue Y; Ma Y Microb Cell Fact; 2018 Aug; 17(1):124. PubMed ID: 30098601 [TBL] [Abstract][Full Text] [Related]
7. Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina Khatri I; Sharma G; Subramanian S BMC Microbiol; 2019 Dec; 19(1):307. PubMed ID: 31888501 [TBL] [Abstract][Full Text] [Related]
8. Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection. Paparo L; Tripodi L; Bruno C; Pisapia L; Damiano C; Pastore L; Berni Canani R Sci Rep; 2020 Jul; 10(1):12636. PubMed ID: 32724066 [TBL] [Abstract][Full Text] [Related]
9. Microbiological and molecular characterization of commercially available probiotics containing Bacillus clausii from India and Pakistan. Patrone V; Molinari P; Morelli L Int J Food Microbiol; 2016 Nov; 237():92-97. PubMed ID: 27543819 [TBL] [Abstract][Full Text] [Related]
10. Comparative study on the interstitial passage of cefuroxime, cefoxitin, cefotaxime and cefoperazone in man by the suction skin blister method. Frongillo RF; Galuppo L; Moretti A Boll Ist Sieroter Milan; 1983 Nov; 62(5):412-6. PubMed ID: 6322818 [TBL] [Abstract][Full Text] [Related]
11. Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii. Girlich D; Leclercq R; Naas T; Nordmann P Antimicrob Agents Chemother; 2007 Nov; 51(11):4009-14. PubMed ID: 17846134 [TBL] [Abstract][Full Text] [Related]
12. Tolerance to challenges miming gastrointestinal transit by spores and vegetative cells of Bacillus clausii. Cenci G; Trotta F; Caldini G J Appl Microbiol; 2006 Dec; 101(6):1208-15. PubMed ID: 17105550 [TBL] [Abstract][Full Text] [Related]
13. Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation. Ghelardi E; Celandroni F; Salvetti S; Gueye SA; Lupetti A; Senesi S J Appl Microbiol; 2015 Aug; 119(2):552-9. PubMed ID: 25973914 [TBL] [Abstract][Full Text] [Related]
14. Biotic and abiotic degradation of four cephalosporin antibiotics in a lake surface water and sediment. Jiang M; Wang L; Ji R Chemosphere; 2010 Sep; 80(11):1399-405. PubMed ID: 20579689 [TBL] [Abstract][Full Text] [Related]
15. Mechanistic Insight into the Role of Peptides Secreted from Guleria J; Khan MA Curr Rev Clin Exp Pharmacol; 2024; 19(4):379-386. PubMed ID: 38375835 [No Abstract] [Full Text] [Related]
16. Bacteremia after Bacillus clausii administration for the treatment of acute diarrhea: A case report. García JP; Hoyos JA; Alzate JA; Cristancho E Biomedica; 2021 Oct; 41(Sp. 2):13-20. PubMed ID: 34669274 [TBL] [Abstract][Full Text] [Related]
17. A chromosomal chloramphenicol acetyltransferase determinant from a probiotic strain of Bacillus clausii. Galopin S; Cattoir V; Leclercq R FEMS Microbiol Lett; 2009 Jun; 296(2):185-9. PubMed ID: 19459958 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic Prospective of a Spore-Forming Probiotic-Bacillus clausii UBBC07 Against Acetaminophen-Induced Uremia in Rats. Patel C; Patel P; Acharya S Probiotics Antimicrob Proteins; 2020 Mar; 12(1):253-258. PubMed ID: 30879230 [TBL] [Abstract][Full Text] [Related]
19. Bacillus Clausii Septicemia in a Pediatric Patient After Treatment With Probiotics. Joshi S; Udani S; Sen S; Kirolikar S; Shetty A Pediatr Infect Dis J; 2019 Sep; 38(9):e228-e230. PubMed ID: 31033906 [TBL] [Abstract][Full Text] [Related]
20. Cometabolic biodegradation of cephalexin by enriched nitrifying sludge: Process characteristics, gene expression and product biotoxicity. Wang B; Ni BJ; Yuan Z; Guo J Sci Total Environ; 2019 Jul; 672():275-282. PubMed ID: 30959294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]